THE USE OF LUPIN CONGLUTIN FOR THE TREATMENT OF TYPE II DIABETES
    5.
    发明授权
    THE USE OF LUPIN CONGLUTIN FOR THE TREATMENT OF TYPE II DIABETES 有权
    使用一个LUPINKONGLUTINS用于II型糖尿病的治疗

    公开(公告)号:EP1605957B1

    公开(公告)日:2008-04-09

    申请号:EP04708771.3

    申请日:2004-02-06

    申请人: INDENA S.p.A.

    IPC分类号: A61K36/48 A61P3/10

    摘要: The present invention discloses the use of lupin conglutin gamma or of proteins showing homology higher than 50% with lupin conglutin gamma, for the preparation of a medicament, food supplements or foods for the treatment of type II diabetes, pharmaceutical and nutritional compositions containing lupin conglutin gamma, and the use of lupin conglutin gamma as therapeutical agent, in particular as hypoglycemizing agent. Lupin conglutin gamma may be used in pure form or in form of extracts, mixtures or concentrates.

    ECHINACEA ANGUSTIFOLIA EXTRACTS
    6.
    发明授权
    ECHINACEA ANGUSTIFOLIA EXTRACTS 有权
    狭叶松果菊提取物

    公开(公告)号:EP1539203B1

    公开(公告)日:2007-09-26

    申请号:EP03783996.6

    申请日:2003-06-30

    申请人: INDENA S.p.A.

    IPC分类号: A61K36/28

    CPC分类号: A61K36/28

    摘要: An Echinacea angustifolia extract and a process for the preparation thereof are herein described. The extract is characterized by an alkylamides content lower than 0.1 %, an echinacoside content ranging from 1 to 10% and containing from 1 to 15% of a polysaccharide characteristic of Echinacea angustifolia. The extract can be used for the treatment of pathological conditions in which it is desirable to strengthen the immune defenses.